JWH-015
SIGMA/J4252 - ≥98% (HPLC), powder
Synonym: (2-
CAS Number: 155471-08-2
Empirical Formula (Hill Notation): C23H21NO
Molecular Weight: 327.42
MDL Number: MFCD02094630
Linear Formula: C23H21NO
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | off-white |
| drug control | regulated under CDSA - not available from Sigma-Aldrich Canada |
| form | powder |
| InChI | 1S/C23H21NO/c1-3-15-24-16 |
| InChI key | LJSBBBWQTLXQEN-UHFFFAOYSA |
| Quality Level | 100 ![]() |
| SMILES string | CCCn1c(C)c(C(=O)c2cccc3cc |
| solubility | DMSO: >20 mg/mL (with heating) |
| storage temp. | −20°C |
| Application: | JWH-015 has been used to study its effect on tumor-evoked pain behavior. It has also been used to study its protective effects on rat brain mitochondria upon paraquat exposure. |
| Biochem/physiol Actions: | JWH-015 is a selective CB2 cannabinoid receptor agonist. JWH-015 is structurally classified as naphthoylindoles. |
| Features and Benefits: | This compound is featured on the Cannabinoid Receptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here . |
| Packaging: | 5, 25 mg in glass bottle |
| Hazard Codes | Xi |
| Risk Statements | 36/37/38 |
| Safety Statements | 26-36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | −20°C |
| UNSPSC | 12352200 |

